Gestonorone: Difference between revisions
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
Kiran Singh (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Drugbox| | {{Drugbox| | ||
|IUPAC_name = (8''R'',9''S'',10''R'',13''S'',14''S'',17''R'')-17-acetyl-17-hydroxy-<br>13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-<br>dodecahydrocyclopenta[a]phenanthren-3-one | |IUPAC_name = (8''R'',9''S'',10''R'',13''S'',14''S'',17''R'')-17-acetyl-17-hydroxy-<br>13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-<br>dodecahydrocyclopenta[a]phenanthren-3-one | ||
| Line 21: | Line 18: | ||
| routes_of_administration= | | routes_of_administration= | ||
}} | }} | ||
__Notoc__ | |||
{{SI}} | {{SI}} | ||
'''Gestonorone''' is a [[ | {{CMG}} | ||
==Overview== | |||
'''Gestonorone''' (or '''17-nydroxy-19-norprogesterone''') is a [[steroid]]al [[progestin]]. | |||
==Synthesis== | |||
Popper, A.; Prezewowsky, K.; Wiechert, R.; Gibian, H.; Raspe, G.; Arnezeimittel Forsh. 1969, 19, 352. | |||
==References== | |||
{{Reflist|2}} | |||
[[Category: | [[Category:Enantiopure drugs]] | ||
[[Category: | [[Category:Progestogens]] | ||
[[Category:Steroids]] | |||
[[Category:Drug]] | |||
Latest revision as of 12:48, 15 April 2015
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C20H28O3 |
| Molar mass | 316.435 g/mol |
|
WikiDoc Resources for Gestonorone |
|
Articles |
|---|
|
Most recent articles on Gestonorone Most cited articles on Gestonorone |
|
Media |
|
Powerpoint slides on Gestonorone |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Gestonorone at Clinical Trials.gov Clinical Trials on Gestonorone at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Gestonorone
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Gestonorone Discussion groups on Gestonorone Patient Handouts on Gestonorone Directions to Hospitals Treating Gestonorone Risk calculators and risk factors for Gestonorone
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Gestonorone |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Gestonorone (or 17-nydroxy-19-norprogesterone) is a steroidal progestin.
Synthesis
Popper, A.; Prezewowsky, K.; Wiechert, R.; Gibian, H.; Raspe, G.; Arnezeimittel Forsh. 1969, 19, 352.
References
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Enantiopure drugs
- Progestogens
- Steroids
- Drug